Professor Lee is a Nuclear Medicine Physician at Austin Health in Melbourne, with extensive nuclear medicine expertise and is very highly regarded in the nuclear medicine community.
Showing 101 - 120 of 318 results
OPAL multi-purpose reactor
Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.
New cell-killing toxin discovered in an environmental pathogen
An international research team has discovered how a bacterial toxin, known as Ssp, is capable of entering and killing a wide range of living cells, including human cells using the Australian Synchrotron.
OPAL 2024 Shutdown
ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.
Chronic kidney disease of unknown origin
In 2017, ANSTO's CEO signed a Memorandum of Understanding with Sri Lanka to work together to investigate the epidemiology of Chronic Kidney Disease of unknown origin (CKDu).
Gentech Generator
Developed by ANSTO’s predecessor the Australian Atomic Energy Commission (known as the AAEC) in the late 1960s, the Technetium-99m Generator revolutionised nuclear medicine imaging in Australia by enabling imaging procedures to be performed not only in major capital cities but throughout regional and rural Australia.
2025 Think Science Competition Summary and Results
Think Science! 2025 Summary and results
Aiding the global research effort on COVID-19
Melbourne researchers map the structure of a key COVID-19 protein using the Australian Synchrotron
Top Coder winner announced
Padstow North and Caringbah North selected as winners of ANSTO's Top Coder competition.
Synchrotron reveals an elusive molecular chameleon
Diversity, Equity, Inclusion and Belonging
At ANSTO we understand that diverse teams produce better outcomes – and we value the merit that a diverse perspective can bring to the quality and outcomes of our work, and the way we get the job done.
Meteorites from the red desert of Australia support search for life on the red planet Mars
Monash University, University of Queensland and Australian National University researchers have used ANSTO’s Australian Synchrotron in their study of meteorites found on Earth that could be used in future to find evidence of life on the planet Mars.
Updates on developments in small modular reactor technologies
There have been significant developments in small modular reactor technologies in 2022. The International Atomic Energy Agency expects small modular reactors (SMRs) to make an important contribution to achieving global climate goals and energy supply security. But with more than 70 SMR designs under development in 18 countries – including innovative reactors that are yet to be licensed and novel methods of modular manufacturing that are new to the nuclear industry – widely deploying SMRs in time remains a tall task.
Physicist to become surrogate inspector
Young physicist in training to become a surrogate inspector for Comprehensive Nuclear Test Ban Treaty Organisation.
Role at ANSTO
Work Health and Safety
ANSTO operates Work Health and Safety and Environmental Management Systems designed to ensure the safety of its employees, partners and members of the public to minimise the impact of our activities on the environment.
Science Highlights - IMBL
A selection of research highlights, instrument news and technical developments for scientists.
Water experts share insights into unique environment of Thirlmere Lakes
ANSTO has produced a comprehensive report for the NSW Department of Planning and Environment that represents a significant scientific investigation of the connections, pathways and processes of water loss from the Thirlmere Lakes system.
Synchrotron-studied protein sheds light on Parkinson’s, stomach cancer, melanoma
Collaboration across the Tasman has enabled Australian and New Zealand researchers and scientists to shed light on a protein involved in diseases such as Parkinson’s disease, gastric cancer and melanoma.
Safeguarding the future of Australia's nuclear medicine
The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.